Caroline Thomason Bunn, RD, CDCES, founder of Caroline Thomason Nutrition , reviewed this article for accuracy.
In the era of precision oncology, the biological underpinnings of LCINS necessitate unique diagnostic and treatment paradigms and warrant consideration of this disease as an important and distinct clinical entity
These readings guide dosage adjustments to skirt hypoglycemia and ensure the transition is as smooth as the insulin it aims to regulate
The activation of GPER has been reported to stimulate the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway [121, 122], resulting in the upregulation of the expression of antioxidant enzymes, including superoxide dismutase (SOD) and glutathione peroxidase (GPx) [123]
Dose Flexibility Some providers offer more flexibility in dosing adjustments, potentially affecting pricing structures